questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines virales
Protéines virales structurales
Protéines de l'enveloppe virale
Protéines de fusion virale
Protéines de fusion virale : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines de fusion virale : Questions médicales les plus fréquentes",
"headline": "Protéines de fusion virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines de fusion virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-13",
"dateModified": "2025-05-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines de fusion virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de l'enveloppe virale",
"url": "https://questionsmedicales.fr/mesh/D014759",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de l'enveloppe virale",
"code": {
"@type": "MedicalCode",
"code": "D014759",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.964.970.880"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Glycoprotéine de spicule des coronavirus",
"alternateName": "Spike Glycoprotein, Coronavirus",
"url": "https://questionsmedicales.fr/mesh/D064370",
"about": {
"@type": "MedicalCondition",
"name": "Glycoprotéine de spicule des coronavirus",
"code": {
"@type": "MedicalCode",
"code": "D064370",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.964.970.880.910.665"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines de fusion virale",
"alternateName": "Viral Fusion Proteins",
"code": {
"@type": "MedicalCode",
"code": "D014760",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jiachen Huang",
"url": "https://questionsmedicales.fr/author/Jiachen%20Huang",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia; Athens, GA 30602, USA."
}
},
{
"@type": "Person",
"name": "Jarrod J Mousa",
"url": "https://questionsmedicales.fr/author/Jarrod%20J%20Mousa",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia; Athens, GA 30602, USA."
}
},
{
"@type": "Person",
"name": "Wen Chang",
"url": "https://questionsmedicales.fr/author/Wen%20Chang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan."
}
},
{
"@type": "Person",
"name": "Rebecca Ellis Dutch",
"url": "https://questionsmedicales.fr/author/Rebecca%20Ellis%20Dutch",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular and Cellular Biochemistry, University of Kentucky, 741 South Limestone Street, Lexington, KY 40536, USA."
}
},
{
"@type": "Person",
"name": "Markus Hoffmann",
"url": "https://questionsmedicales.fr/author/Markus%20Hoffmann",
"affiliation": {
"@type": "Organization",
"name": "Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Use of integrase inhibitors vs protease inhibitors is associated with improved HIV viral suppression.",
"datePublished": "2023-09-07",
"url": "https://questionsmedicales.fr/article/37689245",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajogmf.2023.101151"
}
},
{
"@type": "ScholarlyArticle",
"name": "Influence of class 2 integron integrase concentration on gene cassette insertion and excision in vivo.",
"datePublished": "2023-02-20",
"url": "https://questionsmedicales.fr/article/36808308",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s42770-023-00926-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Structural basis of Ty1 integrase tethering to RNA polymerase III for targeted retrotransposon integration.",
"datePublished": "2023-03-28",
"url": "https://questionsmedicales.fr/article/36977686",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-023-37109-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37434782",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fcimb.2023.1187999"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36522388",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-25979-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines virales",
"item": "https://questionsmedicales.fr/mesh/D014764"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines virales structurales",
"item": "https://questionsmedicales.fr/mesh/D015678"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines de l'enveloppe virale",
"item": "https://questionsmedicales.fr/mesh/D014759"
},
{
"@type": "ListItem",
"position": 7,
"name": "Protéines de fusion virale",
"item": "https://questionsmedicales.fr/mesh/D014760"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines de fusion virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines de fusion virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines de fusion virale",
"description": "Comment diagnostiquer une infection virale liée aux protéines de fusion ?\nQuels tests sont utilisés pour détecter les protéines de fusion ?\nLes biopsies sont-elles utiles pour le diagnostic ?\nQuels symptômes peuvent indiquer une infection virale ?\nLes tests d'imagerie sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Integrases&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines de fusion virale",
"description": "Quels sont les symptômes courants d'une infection virale ?\nLes symptômes varient-ils selon le virus ?\nLes symptômes peuvent-ils être graves ?\nComment les symptômes évoluent-ils avec le temps ?\nLes symptômes sont-ils similaires à ceux d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Integrases&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines de fusion virale",
"description": "Comment prévenir les infections virales ?\nLes masques aident-ils à prévenir la transmission virale ?\nLes voyages augmentent-ils le risque d'infection virale ?\nL'alimentation influence-t-elle la prévention des infections ?\nLes mesures de distanciation sociale sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Integrases&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines de fusion virale",
"description": "Quels traitements sont disponibles pour les infections virales ?\nLes antibiotiques sont-ils efficaces contre les infections virales ?\nLa vaccination peut-elle prévenir les infections virales ?\nLes traitements varient-ils selon le type de virus ?\nLes traitements sont-ils efficaces contre toutes les souches virales ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Integrases&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines de fusion virale",
"description": "Quelles sont les complications possibles des infections virales ?\nLes complications varient-elles selon le virus ?\nComment prévenir les complications des infections virales ?\nLes complications peuvent-elles être mortelles ?\nLes personnes âgées sont-elles plus à risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Integrases&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines de fusion virale",
"description": "Quels sont les principaux facteurs de risque d'infection virale ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes contacts avec des animaux peuvent-ils être un facteur de risque ?\nLes conditions de vie en collectivité augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014760?mesh_terms=Integrases&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection virale liée aux protéines de fusion ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et des cultures virales."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les protéines de fusion ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests ELISA et des techniques de PCR peuvent être utilisés pour détecter ces protéines."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à identifier des infections virales spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, éruptions cutanées et douleurs musculaires peuvent être des indicateurs."
}
},
{
"@type": "Question",
"name": "Les tests d'imagerie sont-ils nécessaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement non, mais ils peuvent être utilisés pour évaluer des complications."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, fatigue, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son type."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être graves ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales peuvent entraîner des complications graves."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver ou s'améliorer selon la réponse immunitaire de l'hôte."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils similaires à ceux d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec ceux de maladies bactériennes ou auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination, l'hygiène des mains et l'évitement des contacts sont essentiels."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir la transmission virale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques peuvent réduire la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle la prévention des infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée renforce le système immunitaire et aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Les mesures de distanciation sociale sont-elles efficaces ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles réduisent la propagation des infections virales dans la communauté."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les soins de soutien et les traitements symptomatiques sont courants."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les infections virales ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les virus, seulement contre les bactéries."
}
},
{
"@type": "Question",
"name": "La vaccination peut-elle prévenir les infections virales ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent prévenir des infections virales spécifiques."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de virus ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut nécessiter un traitement spécifique adapté à son mécanisme."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces contre toutes les souches virales ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines souches peuvent être résistantes aux traitements disponibles."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des infections virales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pneumonie, encéphalite et défaillance organique sont des complications graves."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le virus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut entraîner des complications spécifiques selon son tropisme."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications des infections virales ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et une surveillance médicale peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être mortelles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent entraîner la mort si elles ne sont pas traitées rapidement."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru de complications graves liées aux infections virales."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunodépression, le vieillissement et les conditions de santé préexistantes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones à forte prévalence virale augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les contacts avec des animaux peuvent-ils être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virus zoonotiques peuvent être transmis par contact avec des animaux infectés."
}
},
{
"@type": "Question",
"name": "Les conditions de vie en collectivité augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les environnements surpeuplés favorisent la transmission des infections virales."
}
}
]
}
]
}
Current guidelines for antiretroviral therapy in pregnancy include the use of a dual-nucleoside reverse transcriptase inhibitor with either an integrase strand transfer inhibitor or a ritonavir-booste...
This study aimed to compare viral suppression at delivery among patients on dual-nucleoside reverse transcriptase inhibitors combined with either an integrase strand transfer inhibitor or a protease i...
This study was an observational study of pregnant patients living with HIV who received prenatal care and delivered after 20 weeks of gestation at an urban safety net hospital. All pregnant patients w...
From January 2011 to December 2021, 604 patients on dual-nucleoside reverse transcriptase inhibitor met the inclusion criteria, including 411 patients (68%) on protease inhibitor and 193 patients (32%...
Among pregnant patients living with HIV, viral suppression was more common among those on a dual-nucleoside reverse transcriptase inhibitor backbone combined with integrase strand transfer inhibitor t...
Integron can capture and express antimicrobial resistance gene cassettes and plays important roles in horizontal gene transfer. The establishment of a complete in vitro reaction system will help to re...
The yeast Ty1 retrotransposon integrates upstream of genes transcribed by RNA polymerase III (Pol III). Specificity of integration is mediated by an interaction between the Ty1 integrase (IN1) and Pol...
Second-generation integrase strand transfer inhibitors (INSTIs) are preferred treatment options worldwide, and dolutegravir (DTG) is the treatment of choice in resource-limited settings. Nevertheless,...
Real-world study of adults living with HIV who initiated integrase INSTIs DTG, EVG/c, and RAL-based regimens in three settings (ART-naïve patients, ART-switching, and ART-salvage patients). The primar...
Virological effectiveness of EVG/c- and RAL-based regimens was similar to that of DTG when given as first-line and salvage therapy. Treatment switching for reasons other than virological failure was m...
Whereas second-generation INSTIs are preferred treatment options worldwide, and DTG is one of the treatment of choices in resource-limited settings, first-generation INSTIs may still provide high viro...
Viruses are the most abundant components of the human gut microbiome with a significant impact on health and disease. The effects of human immunodeficiency virus (HIV) infection on gut virome has been...
Seamless DNA vectors derived from bacterial plasmids are devoid of bacterial genetic elements and represent attractive alternatives for biomedical applications including DNA vaccines. Larger scale pro...
Integrase strand transfer inhibitors (INSTIs), including raltegravir (RAL), dolutegravir (DTG), elvitegravir (EVG), bictegravir (BIC), and cabotegravir (CAB), are increasingly used, given excellent da...
Advances in synthetic biology, bioengineering, and computation allow us to rapidly and reliably program cells with increasingly complex and useful functions. However, because the functions we engineer...
Agrobacterium tumefaciens, the causal agent of plant crown gall disease, has been widely used to genetically transform many plant species. The inter-kingdom gene transfer capability made Agrobacterium...
Further investigations into the relationship between integrase strand transfer inhibitors (INSTIs) and weight gain are required, especially whether ceasing INSTI results in weight loss. We evaluated w...